CA80907/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2002	3
2003	3
2004	1
2005	2
2007	1
2008	2
2009	1
2010	1
2022	0

1

The Ki-67 index and survival in non-small cell lung cancer: a review and relevance to positron emission tomography.

Pugsley JM, Schmidt RA, Vesselle H. Pugsley JM, et al. Cancer J. 2002 May-Jun;8(3):222-33. doi: 10.1097/00130404-200205000-00003. Cancer J. 2002. PMID: 12074319 Review.

2

18F-Fluorothymidine radiation dosimetry in human PET imaging studies.

Vesselle H, Grierson J, Peterson LM, Muzi M, Mankoff DA, Krohn KA. Vesselle H, et al. J Nucl Med. 2003 Sep;44(9):1482-8. J Nucl Med. 2003. PMID: 12960196 Free article. Clinical Trial.

3

Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.

Muzi M, Mankoff DA, Grierson JR, Wells JM, Vesselle H, Krohn KA. Muzi M, et al. J Nucl Med. 2005 Feb;46(2):371-80. J Nucl Med. 2005. PMID: 15695799 Free article.

4

DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.

Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, Jordan CD, Kiviat NB, Vesselle H. Feng Q, et al. Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):645-54. doi: 10.1158/1055-9965.EPI-07-2518. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18349282 Free PMC article.

5

PET-CT image registration in the chest using free-form deformations.

Mattes D, Haynor DR, Vesselle H, Lewellen TK, Eubank W. Mattes D, et al. IEEE Trans Med Imaging. 2003 Jan;22(1):120-8. doi: 10.1109/TMI.2003.809072. IEEE Trans Med Imaging. 2003. PMID: 12703765

6

Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.

Muzi M, Vesselle H, Grierson JR, Mankoff DA, Schmidt RA, Peterson L, Wells JM, Krohn KA. Muzi M, et al. J Nucl Med. 2005 Feb;46(2):274-82. J Nucl Med. 2005. PMID: 15695787 Free article. Clinical Trial.

7

Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.

Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, Vallières E, Wood DE. Vesselle H, et al. J Thorac Oncol. 2008 Sep;3(9):971-8. doi: 10.1097/JTO.0b013e31818307a7. J Thorac Oncol. 2008. PMID: 18758298 Free article.

8

DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.

Hawes SE, Stern JE, Feng Q, Wiens LW, Rasey JS, Lu H, Kiviat NB, Vesselle H. Hawes SE, et al. Lung Cancer. 2010 Aug;69(2):172-9. doi: 10.1016/j.lungcan.2009.11.002. Epub 2009 Nov 28. Lung Cancer. 2010. PMID: 19945765 Free PMC article. Clinical Trial.

9

Application of a neural network to improve nodal staging accuracy with 18F-FDG PET in non-small cell lung cancer.

Vesselle H, Turcotte E, Wiens L, Haynor D. Vesselle H, et al. J Nucl Med. 2003 Dec;44(12):1918-26. J Nucl Med. 2003. PMID: 14660717 Free article.

10

In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors.

Vesselle H, Grierson J, Muzi M, Pugsley JM, Schmidt RA, Rabinowitz P, Peterson LM, Vallières E, Wood DE. Vesselle H, et al. Clin Cancer Res. 2002 Nov;8(11):3315-23. Clin Cancer Res. 2002. PMID: 12429617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results